Skip to content

Comparison of Laparoscopic Surgery Versus Open Surgery in the Treatment of Adhesive Small Bowel Obstruction

Laparoscopic Versus Open Adhesiolysis for Small Bowel Obstruction - A Multicenter, Prospective, Randomized, Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01867528
Enrollment
102
Registered
2013-06-04
Start date
2013-07-31
Completion date
Unknown
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Small Bowel Obstruction

Brief summary

Small bowel obstruction is a common reason for surgical admission. Most common reason for small bowel obstruction is adhesions, which account up to 70-80 % of small bowel obstructions. Large proportion of adhesive small bowel obstructions may be treated nonoperatively, but up to 50-60% may need surgical intervention. Current golden standard for surgical intervention is open adhesiolysis. Recently, retrospective studies have provided encouraging results of laparoscopic adhesiolysis for small bowel obstructions. However, no prospective randomized trials have been carried out and retrospective series carries a high risk for patient selection and bias. Although in general laparoscopy has been associated with shortened hospital stay, less pain and reduced mortality, laparoscopic adhesiolysis for small bowel obstruction has been reported to cause iatrogenic small bowel lesions up to 7% of patients. Aim of the study is to compare open adhesiolysis to laparoscopic adhesiolysis. The investigators hypothesis is that laparoscopic adhesiolysis is safe, will shorten the hospital stay, and reduce mortality compared to open approach.

Interventions

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years

Inclusion criteria

* All patients with clinical and computed tomography-diagnosed adhesive small bowel obstruction AND * Obstruction is not relieved by conservative methods (nasogastric tube, NPO) including Gastrografin is not passed to colon within 8 hours (48-hour conservative treatment without Gastrografin® is allowed if Gastrografin® is contraindicated (e.g. allergy) or not available)

Exclusion criteria

* Strong suspicion of strangulation or clinical peritonitis thus indicating an urgent operative intervention * Earlier confirmed or strongly suspected peritoneal carcinosis * Earlier confirmed wide diffuse adhesions of abdominal cavity * Earlier open surgery for endometriosis * Earlier generalized diffuse peritonitis (not including local peritonitis such as appendicitis) * Active abdominal malignancy or remission less than 10 years * Earlier abdominal region radiotherapy * Earlier obesity surgery * 3 or more earlier open abdominal operations (not including caesarean section(s)) * Suspicion of other cause for obstruction than adhesions in CT-scan * Earlier abdominal surgical operation within 30 days * Earlier surgical operation for aorta or iliac vessels performed through laparotomy * Crohn's disease * Anesthesiological contraindication for laparoscopy * Missing informed consent * Age less than 18 years or over 95 years * Pregnancy * Patient living in institutional care (such as health centre ward), not including retirement homes * Over 1 week of hospital stay directly prior surgical consultation

Design outcomes

Primary

MeasureTime frame
Post-operative hospital stay (days)Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days

Secondary

MeasureTime frame
Commence of enteral nutrition (post-operative days)Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Mortality30 days after randomization
Complications, Clavien-Dindo classification30 days after randomization
Number of participants with iatrogenic small bowel lesionsParticipants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Number of participants with readmission(s)30 days after randomization
Number of participant with failure to relieve obstructionParticipants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Passage of stools (post-operative days)Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Length of epidural catheter analgesia (days)Participants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Total need of opioids in milligramsParticipants will be followed for the duration of post-operative hospital stay, an expected average of 7 days
Length of sick leave (days)Participants will be followed for the duration of sick leave, depending on occupation estimated 1-4 weeks
Number of participants that develop ventral hernia10 years
Number of patient with recurrent adhesive small bowel obstruction10 years
Pain scores on the Visual Analog ScalePostoperative days 1- 7 or till discharge

Countries

Finland, Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026